These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 32770956

  • 1. The burden of hyperkalemia in Germany - a real world evidence study assessing the treatment and costs of hyperkalemia.
    Haas JS, Krinke KS, Maas C, Hardt T, Barck I, Braun S.
    BMC Nephrol; 2020 Aug 08; 21(1):332. PubMed ID: 32770956
    [Abstract] [Full Text] [Related]

  • 2. The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings.
    Neuenschwander JF, Silverstein AR, Teigland CL, Kumar S, Zeng EY, Agiro AT, Pottorf WJ, Peacock WF.
    Adv Ther; 2023 Mar 08; 40(3):1204-1223. PubMed ID: 36652174
    [Abstract] [Full Text] [Related]

  • 3. Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure.
    Polson M, Lord TC, Kangethe A, Speicher L, Farnum C, Brenner M, Oestreicher N, Alvarez P.
    J Manag Care Spec Pharm; 2017 Apr 08; 23(4-a Suppl):S2-S9. PubMed ID: 28436256
    [Abstract] [Full Text] [Related]

  • 4. Healthcare resource utilisation and cost associated with elevated potassium levels: a Danish population-based cohort study.
    Kim K, Thomsen RW, Nicolaisen SK, Hasvold LP, Palaka E, Sørensen HT.
    BMJ Open; 2019 Apr 01; 9(4):e026465. PubMed ID: 30940761
    [Abstract] [Full Text] [Related]

  • 5. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M, De Francesco M, Iannazzo S, Garofalo C, Andreucci M, Genualdo R, Borrelli S, Minutolo R, Conte G, De Nicola L.
    Int J Clin Pract; 2020 May 01; 74(5):e13475. PubMed ID: 31909866
    [Abstract] [Full Text] [Related]

  • 6. [Effect of hyperkalemia and RAASi nonadherence on patients affected by heart failure or chronic kidney disease].
    Degli Esposti L, Perrone V, Giacomini E, Sangiorgi D, Alessandrini D, Santoro A.
    G Ital Nefrol; 2019 Sep 24; 36(5):. PubMed ID: 31580544
    [Abstract] [Full Text] [Related]

  • 7. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
    Caravaca-Fontán F, Valladares J, Díaz-Campillejo R, Barroso S, Luna E, Caravaca F.
    Nefrologia (Engl Ed); 2019 Sep 24; 39(5):513-522. PubMed ID: 31027897
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K).
    Jin H, Lu R, Zhang L, Yao L, Shao G, Zuo L, Qin S, Zhang X, Zhang Q, Yu W, Luo Q, Ren Y, Peng H, Xiao J, Yang Q, Chen Q, Shi Y, Ni Z.
    Ren Fail; 2024 Dec 24; 46(2):2384585. PubMed ID: 39252179
    [Abstract] [Full Text] [Related]

  • 10. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study.
    Thomsen RW, Nicolaisen SK, Hasvold P, Sanchez RG, Pedersen L, Adelborg K, Egstrup K, Egfjord M, Sørensen HT.
    Nephrol Dial Transplant; 2018 Sep 01; 33(9):1610-1620. PubMed ID: 29177463
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Real-world management of hyperkalemia with patiromer among United States Veterans.
    Kovesdy CP, Gosmanova EO, Woods SD, Fogli JJ, Rowan CG, Hansen JL, Sauer BC.
    Postgrad Med; 2020 Mar 01; 132(2):176-183. PubMed ID: 31971043
    [Abstract] [Full Text] [Related]

  • 13. Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology.
    Bianchi S, Aucella F, De Nicola L, Genovesi S, Paoletti E, Regolisti G.
    J Nephrol; 2019 Aug 01; 32(4):499-516. PubMed ID: 31119681
    [Abstract] [Full Text] [Related]

  • 14. Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis.
    Muhlestein JB, Kammerer J, Bair TL, Knowlton KU, Le VT, Anderson JL, Lappé DL, May HT.
    BMC Prim Care; 2022 Apr 01; 23(1):65. PubMed ID: 35365076
    [Abstract] [Full Text] [Related]

  • 15. Hyperkalemia Recurrence Following Medical Nutrition Therapy in Patients with Stage 3-4 Chronic Kidney Disease: The REVOLUTIONIZE I Real-World Study.
    Rowan CG, Agiro A, Chan KA, Colman E, White K, Desai P, Dwyer JP.
    Adv Ther; 2024 Jun 01; 41(6):2381-2398. PubMed ID: 38687454
    [Abstract] [Full Text] [Related]

  • 16. The Impact of Hyperkalemia on Mortality and Healthcare Resource Utilization Among Patients With Chronic Kidney Disease: A Matched Cohort Study in China.
    Zhang J, He X, Wu J.
    Front Public Health; 2022 Jun 01; 10():855395. PubMed ID: 35400057
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis.
    Chang TI, Zheng Y, Montez-Rath ME, Winkelmayer WC.
    Clin J Am Soc Nephrol; 2016 Aug 08; 11(8):1401-1412. PubMed ID: 27354656
    [Abstract] [Full Text] [Related]

  • 18. Prevalence, clinical impact and costs of hyperkalaemia: Special focus on heart failure.
    Maggioni AP, Dondi L, Andreotti F, Calabria S, Iacoviello M, Gorini M, Gonzini L, Piccinni C, Ronconi G, Martini N.
    Eur J Clin Invest; 2021 Aug 08; 51(8):e13551. PubMed ID: 33786826
    [Abstract] [Full Text] [Related]

  • 19. Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey.
    Rossignol P, Lamiral Z, Frimat L, Girerd N, Duarte K, Ferreira J, Chanliau J, Castin N.
    Nephrol Dial Transplant; 2017 Dec 01; 32(12):2112-2118. PubMed ID: 28460113
    [Abstract] [Full Text] [Related]

  • 20. Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patients.
    Desai NR, Alvarez PJ, Golestaneh L, Woods SD, Coca SG, Rowan CG.
    J Med Econ; 2021 Dec 01; 24(1):1025-1036. PubMed ID: 34357841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.